This page shows Invesco CurrencyShares® Canadian Dollar Trust (FXC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A cash-backed, pass-through trust where capital flows reshape the balance sheet more than operating earnings do.
The FY2025 asset rebound was driven far more by a financing inflow of$10.1M than by net income of$387K , so balance-sheet size is being set mainly by capital flows, not by retained profit, and the trust's scale can change quickly even when reported earnings are modest. That interpretation matches a near-fully cash-backed structure: FY2025 cash of$74.9M sat against only$60K of liabilities.
FY2025 dividends paid of
Across the last three valid years, operating cash flow closely tracked net income, including FY2025 cash from operations of
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Invesco CurrencyShares® Canadian Dollar Trust's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Invesco CurrencyShares® Canadian Dollar Trust's revenue declined 52.2% year-over-year, from $1.5M to $714K. This contraction results in a growth score of 0/100.
Invesco CurrencyShares® Canadian Dollar Trust carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
Invesco CurrencyShares® Canadian Dollar Trust generates a 0.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 14/100. This is down from 2.0% the prior year.
Invesco CurrencyShares® Canadian Dollar Trust passes 3 of 9 financial strength tests. 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Invesco CurrencyShares® Canadian Dollar Trust generates $1.12 in operating cash flow ($435K OCF vs $387K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Invesco CurrencyShares® Canadian Dollar Trust generated $714K in revenue in fiscal year 2025. This represents a decrease of 52.2% from the prior year.
Invesco CurrencyShares® Canadian Dollar Trust reported $387K in net income in fiscal year 2025. This represents a decrease of 68.9% from the prior year.
Invesco CurrencyShares® Canadian Dollar Trust earned $0.33 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 76.9% from the prior year.
Cash & Balance Sheet
Invesco CurrencyShares® Canadian Dollar Trust held $74.9M in cash against $0 in long-term debt as of fiscal year 2025.
Invesco CurrencyShares® Canadian Dollar Trust paid $0.37 per share in dividends in fiscal year 2025. This represents a decrease of 75.8% from the prior year.
Invesco CurrencyShares® Canadian Dollar Trust had 1M shares outstanding in fiscal year 2025. This represents an increase of 22.2% from the prior year.
Margins & Returns
Invesco CurrencyShares® Canadian Dollar Trust's net profit margin was 54.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 29.1 percentage points from the prior year.
Invesco CurrencyShares® Canadian Dollar Trust's ROE was 0.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.5 percentage points from the prior year.
Capital Allocation
FXC Income Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $104K-14.0% | $121K-42.2% | $209K+7.3% | $195K+3.1% | $189K-30.3% | $271K-25.1% | $362K-9.9% | $402K |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | N/A | N/A | N/A | $0 | N/A | N/A | N/A |
| Net Income | $24K-39.1% | $39K-66.6% | $116K+4.7% | $110K-10.1% | $123K-41.3% | $209K-30.3% | $300K-12.5% | $343K |
| EPS (Diluted) | $0.02 | N/A | $0.090.0% | $0.09-25.0% | $0.12 | N/A | $0.35-14.6% | $0.41 |
FXC Balance Sheet
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $84.1M+12.2% | $74.9M-18.0% | $91.4M-1.9% | $93.2M+37.1% | $68.0M+11.0% | $61.2M-0.6% | $61.6M+7.6% | $57.3M |
| Current Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $84.0M+12.2% | $74.9M-18.0% | $91.3M-1.9% | $93.1M+37.1% | $67.9M+11.0% | $61.2M-0.5% | $61.5M+7.6% | $57.1M |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $29K-52.7% | $60K+101.1% | $30K+0.5% | $30K+19.8% | $25K+20.3% | $21K-8.8% | $23K+21.2% | $19K |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $84.0M+12.3% | $74.9M-18.0% | $91.3M-1.9% | $93.2M+37.1% | $67.9M+11.0% | $61.2M-0.6% | $61.6M+7.6% | $57.2M |
| Retained Earnings | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
FXC Cash Flow Statement
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $23K-64.0% | $64K-47.9% | $122K+13.8% | $107K-24.9% | $143K-41.7% | $245K-21.4% | $311K-14.2% | $363K |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $10.6M+160.7% | -$17.5M-13394.9% | -$130K-100.6% | $21.0M+210.5% | $6.8M+106.6% | $3.3M+5.5% | $3.1M+1027.6% | -$334K |
| Dividends Paid | $23K-62.1% | $61K-50.1% | $122K+10.2% | $111K-22.4% | $143K-42.1% | $246K-20.9% | $311K-11.9% | $353K |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
FXC Financial Ratios
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 22.6%-9.3pp | 31.9%-23.3pp | 55.3%-1.4pp | 56.6%-8.3pp | 64.9%-12.2pp | 77.1%-5.8pp | 82.9%-2.5pp | 85.4% |
| Return on Equity | 0.0%-0.0pp | 0.1%-0.1pp | 0.1%+0.0pp | 0.1%-0.1pp | 0.2%-0.2pp | 0.3%-0.1pp | 0.5%-0.1pp | 0.6% |
| Return on Assets | 0.0%-0.0pp | 0.1%-0.1pp | 0.1%+0.0pp | 0.1%-0.1pp | 0.2%-0.2pp | 0.3%-0.1pp | 0.5%-0.1pp | 0.6% |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.000.0 | 0.00 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |